# Nasal Immune Challenge Study

> **NCT06021002** · NA · UNKNOWN · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 24 (estimated)

## Conditions studied

- Innate Inflammatory Response
- Asthma
- Nasal Allergy

## Interventions

- **DRUG:** R848
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06021002
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-09
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06021002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06021002, "Nasal Immune Challenge Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06021002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*